0000905718-21-000315.txt : 20210225 0000905718-21-000315.hdr.sgml : 20210225 20210225122713 ACCESSION NUMBER: 0000905718-21-000315 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210225 DATE AS OF CHANGE: 20210225 EFFECTIVENESS DATE: 20210225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Arch Therapeutics, Inc. CENTRAL INDEX KEY: 0001537561 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 460524102 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-390512 FILM NUMBER: 21678329 BUSINESS ADDRESS: STREET 1: 235 WALNUT STREET, SUITE 6 CITY: FRAMINGHAM STATE: MA ZIP: 01702 BUSINESS PHONE: 617-431-2313 MAIL ADDRESS: STREET 1: 235 WALNUT STREET, SUITE 6 CITY: FRAMINGHAM STATE: MA ZIP: 01702 FORMER COMPANY: FORMER CONFORMED NAME: ALMAH,INC DATE OF NAME CHANGE: 20111216 D 1 primary_doc.xml X0708 D LIVE 0001537561 Arch Therapeutics, Inc. 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA MASSACHUSETTS 01702 617-431-2313 NEVADA ALMAH, INC Almah, Inc. ALMAH,INC Corporation true Terrence W. Norchi 235 Walnut Street, Suite 6 Framingham MA MASSACHUSETTS 01702 Executive Officer Director Punit Dhillon 235 Walnut Street, Suite 6 Framingham MA MASSACHUSETTS 01702 Director James R. Sulat 235 Walnut Street, Suite 6 Framingham MA MASSACHUSETTS 01702 Director Richard E. Davis 235 Walnut Street, Suite 6 Framingham MA MASSACHUSETTS 01702 Executive Officer Biotechnology Decline to Disclose 06b false 2021-02-11 false true true true false 0 H.C. Wainwright & Co. 375 None None 430 PARK AVENUE, 4TH FLOOR NEW YORK NY NEW YORK 10022 All States false 7520000 6900000 620000 false 9 492750 true 0 Excludes value of warrants to purchase up to 3,234,375 shares at an exercise price of $0.20 per share 0 true Some of the proceeds may be used for general working capital purposes including the payment of salaries and other fees to those listed in Item 3. false Arch Therapeutics, Inc. /s/ Terrrence Norchi Terrence Norchi President, Chief Executive Officer 2021-02-25